#United States #New York #Class Action #Securities Fraud #Inspire Medical Systems

Inspire Medical Systems Class Action Lawsuit Notification

On November 14, 2025, Levi & Korsinsky LLP announced significant news for investors in Inspire Medical Systems, Inc. (NYSE: INSP). The law firm has commenced a class action securities lawsuit aimed at addressing alleged fraudulent activities that may have caused financial harm to investors between August 6, 2024, and August 4, 2025. Investors impacted by these claims are urged to take action promptly as there are important deadlines to consider.

Understanding the Class Action Lawsuit

The central aim of this lawsuit is to recover losses for shareholders of Inspire Medical Systems who are believed to have suffered due to alleged securities fraud. The lawsuit focuses on the launch of the company's latest medical device, Inspire V, which was portrayed positively by company executives. However, the reality, as disclosed in the filed complaint, was starkly different.

Key Allegations: The lawsuit alleges that the company representatives allegedly made misleading statements regarding the success and demand for the Inspire V product. It was reported that the launch failed significantly; providers remained hesitant due to an overwhelming backlog of existing inventory, and necessary preparatory actions were left incomplete.

Specific areas of negligence included:

• - Incomplete training for treatment centers.
• - Failure to establish essential IT infrastructures needed for operational success.
• - Lack of preparedness regarding Medicare reimbursement processes.

What Investors Should Know

If you have experienced a financial setback in your investment in Inspire Medical Systems during the specified period, it is crucial to be aware of the impending deadline to become a class representative. Investors have until January 5, 2026, to put forth their request for court appointment as lead plaintiff in this class action. Notably, it's important to understand that participating in the lawsuit doesn’t necessitate serving as the lead plaintiff to be eligible for potential recovery.

No Financial Obligation: For those who qualify, participating in this class action will not incur any fees or out-of-pocket costs, thus allowing individuals to seek potential compensation without financial risk.

Why Choose Levi & Korsinsky?

Levi & Korsinsky's reputation as a formidable advocate for shareholder rights, built over two decades, underscores their credibility. They've secured substantial recoveries for investors over the years and have consistently ranked as one of the leading securities litigation firms in the United States.

The dedicated team at Levi & Korsinsky includes over 70 professionals whose expertise focuses on complex securities litigation, providing clients with personalized and effective representation.

For those wishing to explore their options, Levi & Korsinsky is readily available for inquiries. Investors can reach Joseph E. Levi, Esq. at the firm's New York office, highlighting their commitment to support affected shareholders.

Take Action Now

This case serves as a reminder of the inherent volatility of the stock market and the importance of remaining vigilant as an investor. If you are affected by these developments involving Inspire Medical Systems, now is the time to assess your options and get in touch with legal representatives who can guide you through your next steps.

For further information regarding this lawsuit and its implications, investors can visit Levi & Korsinsky's official website or contact their office directly.